Advertisement
Screener

Cardinal Health, Inc. (CAH) ROE

CARDINAL HEALTH INC ROE

Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • CARDINAL HEALTH INC roe for the quarter ending 2025-12-31 was -57.63%, a change of -13.76% year-over-year.
  • CARDINAL HEALTH INC roe for the quarter ending 2025-09-30 was -55.40%, a change of -16.34% year-over-year.
  • CARDINAL HEALTH INC roe for the quarter ending 2025-06-30 was -56.13%, a change of -29.61% year-over-year.
  • CARDINAL HEALTH INC roe for the quarter ending 2025-03-31 was -52.82%, a change of -33.76% year-over-year.
  • CARDINAL HEALTH INC roe for fiscal 2026 was -59.45%, a change of -3.32% from fiscal 2025.
  • CARDINAL HEALTH INC roe for fiscal 2025 was -56.13%, a change of -29.61% from fiscal 2024.
  • CARDINAL HEALTH INC roe for fiscal 2024 was -26.52%, a change of -15.36% from fiscal 2023.
  • CARDINAL HEALTH INC roe for fiscal 2023 was -11.16%, a 108.43% decline from fiscal 2022.
Available history
2008-06-30 to 2026-06-30
Data captured

Historical ROE

DateROENet income 12 monthNet income 3 monthShareholder equity
2025-12-31-57.63%$1.66B$467.00M-$2.88B
2025-09-30-55.40%$1.6B$450.00M-$2.88B
2025-06-30-56.13%$1.56B$239.00M-$2.78B
2025-03-31-52.82%$1.56B$506.00M-$2.95B
2024-12-31-43.86%$1.31B$400.00M-$2.99B
2024-09-30-39.06%$1.28B$416.00M-$3.28B
2024-06-30-26.52%$852M$235.00M-$3.21B
2024-03-31-19.05%$622M$261.00M-$3.27B
2023-12-31-20.47%$706M$368.00M-$3.45B
2023-09-30-5.96%$208M-$12.00M-$3.49B
2023-06-30-11.16%$330M$5.00M-$2.96B
2023-03-31-20.63%$458M$365.00M-$2.22B
2022-12-3157.75%-$1.28B-$77.00M-$2.21B
2022-09-3061.71%-$1.1B$98.00M-$1.78B
2022-06-30132.30%-$938M$133.00M-$709M
2022-03-31137.02%-$955M-$1.39B-$697M
2021-12-3155.61%$555M$49.00M$998M
2021-09-3081.48%$1.14B$271.00M$1.39B
2021-06-3034.12%$611M$116.00M$1.79B
2021-03-3164.30%$1.15B$119.00M$1.79B
2020-12-3170.12%$1.38B$629.00M$1.97B
2020-09-3068.42%$973M-$253.00M$1.42B
2020-06-30-206.60%-$3.7B$656.00M$1.79B
2020-03-31-345.64%-$4.16B$350.00M$1.2B
2019-12-31-421.62%-$4.21B$220.00M$999M
2019-09-30-461.33%-$4.15B-$4.92B$900M
2019-06-3021.54%$1.36B$194.00M$6.33B
2019-03-310.05%$3M$296.00M$6.23B
2018-06-304.24%$257M-$1.17B$6.06B
2018-03-3122.52%$1.7B$255.00M$7.54B
2017-12-3123.99%$1.82B$1.05B$7.6B
2017-09-3016.38%$1.09B$115.00M$6.68B
2017-06-3018.92%$1.29B$274.00M$6.81B
2017-03-3120.25%$1.35B$381.00M$6.65B
2016-12-3121.37%$1.35B$324.00M$6.32B
2016-09-3020.78%$1.35B$309.00M$6.51B
2016-06-3021.77%$1.43B$333.00M$6.55B
2016-03-3120.71%$1.39B$386.00M$6.71B
2015-12-3120.40%$1.37B$326.00M$6.71B
2015-09-3020.48%$1.33B$383.00M$6.51B
2015-06-3019.42%$1.22B$295.00M$6.26B
2015-03-3118.12%$1.15B$365.00M$6.37B
2014-12-3118.10%$1.1B$289.00M$6.1B
2014-09-3017.47%$1.09B$266.00M$6.26B
2014-06-3018.22%$1.17B$234.00M$6.4B
2014-03-315.30%$346M$315.00M$6.53B
2013-12-315.71%$376M$278.00M$6.59B
2013-09-306.37%$401M$339.00M$6.3B
2013-06-305.57%$333M-$586.00M$5.98B
2013-03-3116.93%$1.16B$345.00M$6.83B
2012-12-3117.49%$1.14B$303.00M$6.54B
2012-09-3017.56%$1.1B$271.00M$6.28B
2012-06-3017.12%$1.07B$236.00M$6.24B
2012-03-3116.58%$1.03B$333.00M$6.24B
2011-12-3115.99%$947.7M$262.00M$5.93B
2011-09-3015.77%$901.1M$237.00M$5.71B
2011-06-3016.39%$958.9M$203.00M$5.85B
2011-03-3117.32%$979.5M$246.00M$5.66B
2010-12-3117.63%$955.9M$215.40M$5.42B
2010-09-3018.61%$975M$295.00M$5.24B
2010-06-3012.17%$642M$223.50M$5.28B
2010-03-3112.91%$691.9M$222.40M$5.36B
2009-12-3114.97%$782.4M$234.50M$5.23B
2009-09-3017.49%$864.4M-$38.20M$4.94B
2009-06-3013.20%$1.15B$273.20M$8.73B

Annual ROE

DateROENet income 12 monthShareholder equity
2026-06-30-59.45%$1.71B-$2.88B
2025-06-30-56.13%$1.56B-$2.78B
2024-06-30-26.52%$852M-$3.21B
2023-06-30-11.16%$330M-$2.96B
2022-06-30132.30%-$938M-$709M
2021-06-3034.12%$611M$1.79B
2020-06-30-206.60%-$3.7B$1.79B
2019-06-3021.54%$1.36B$6.33B
2018-06-304.23%$256M$6.06B
2017-06-3018.92%$1.29B$6.81B
2016-06-3021.77%$1.43B$6.55B
2015-06-3019.42%$1.22B$6.26B
2014-06-3018.22%$1.17B$6.4B
2013-06-305.59%$334M$5.98B
2012-06-3017.12%$1.07B$6.24B
2011-06-3016.40%$959M$5.85B
2010-06-3012.17%$642M$5.28B
2009-06-3013.20%$1.15B$8.73B
2008-06-3016.79%$1.3B$7.75B

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cencora, Inc. (COR)United States$59.130B20.57
MCKESSON CORP (MCK)United States$101.317B19.78
HERBALIFE LTD. (HLF)$1.281B8.39
NU SKIN ENTERPRISES, INC. (NUS)United States$0.225B-1.18
Cosmos Health Inc. (COSM)Greece$0.038B-0.60
HWH International Inc. (HWH)United States$0.021B-4.08
DataMeds AI, Inc. (MEDS)United States$0.011B